Rescuing the Function of Mutated Isocitrate Dehydrogenase by Strychalski, Joshua et al.
Authors: Joshua Strychalski, Rizwan Ahmed, and Ryan Lubelski 
Indiana University South Bend, Department of Chemistry and Biochemistry,  
South Bend Indiana, USA  46634 
Acknowledgments 
 
Gretchen Anderson (Ph.D) – Indiana University South Bend 
Shahir Rizk (Ph.D) – University of Chicago 
Aaron Gill – Indiana University South Bend 
Abstract 
Isocitrate dehydrogenase (IDH1), an enzyme involved in the conversion of isocitrate into α-
ketoglutarate, is an important enzyme in the citric acid cycle—a primary source of energy for 
the human body.  A mutation in IDH1 disrupts its structure and overall functionality, leading to 
the high probability of developing aggressive brain tumors. In order to assess and repair this 
impairment, two synthetic binders, or FABs, were used to determine the effect on the activity of 
mutant IDH1. Comparison of the activities of these two different FABs revealed to what degree 
the activity of this enzyme was restored. The wild-type activity for IDH1 is greater than the 
activity of the mutant enzyme without the presence of any FABs. With the presence of FAB4, 
the activity was increased a significant degree. In comparison, FAB5 exhibits an opposite effect 
on the activity of the enzyme, lowering the enzyme’s activity considerably. FAB4 helped to 
bring the activity of mutated IDH1 closer to that of wild-type IDH1; from this result, it’s 
possible that FAB4 has the potential to lead to the development of a potential therapeutic agent. 
In the citric acid cycle, isocitrate dehydrogenase (IDH1) catalyzes the conversion of isocitrate 
into α-ketoglutarate, a key metabolic step. In certain aggressive brain tumors, the IDH1 obtains a 
single point mutation at arginine 132, causing the enzyme to change its conformation so that it 
now converts α-ketoglutarate into 2-hydroxyglutarate.  In order to repair the activity of this 
enzyme, randomly generated antibody fragments (FABs) could be selected to bind to the 
mutated IDH1. One or more of these fabricated FABs may restore the natural function of the 
mutated IDH1 by forcing the enzyme back into its native conformation. Is so, these FABs could 
potentially lead to the development of a drug that could be used to treat grade II-III gliomas.  
 
Conclusions 
 Mutant IDH1 has been found in up to 80% of aggressive brain tumors. In order to repair the 
function of this mutant enzyme, the restorative potentials of two FABs were assessed. FAB5 
appears to act as an inhibitor of IDH1, increasing the Km of mutant IDH1 from 130 mM to 
150 mM. In contrast, FAB4 appears to have a positive effect on mutant IDH1 activity, 
decreasing the Km of mutant IDH1 from 130 mM to 76 mM. This suggests that FAB4 is acting 
as an activator, restoring the function of IDH1 activity to some degree. Although FAB4 does 
not fully restore the function of mutant IDH1 so that it better resembles the wild-type (Km = 
0.001), it does have the potential to one day lead to the development of an effective therapeutic 
application. 
Method  
Structural Differences Between Wild-Type IDH1 and Mutant IDH1 
Figure 2: Km values calculated for mutant IDH1 and mutant IDH1 + FABs. 
Using Antibodies As Drugs to Restore Protein Function 
Figure 1: Double-reciprocal plot of 1/Vmax vs. 1/Km for mutant IDH1 and mutant IDH1 + FABs 
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(literature value) 
0.0110 n/a 
Mutant IDH1 130 1.6 x10-5 
Mutant IDH1 + FAB4 76 1.3 x 10-5 
 Mutant IDH1 + FAB5 150 2.5 x 10-5 
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In the Lineweaver-Burke plot above, the x- and y-intercepts correspond to -1/Km and 1/Vmax respectively. 
Vmax indicates how fast an enzyme can produce product when the concentration of substrate is saturated. Km 
is the concentration of substrate that is required to reach ½ Vmax. For this experiment, changes in Km are 
noteworthy. If the Km is lower, then less substrate is required to reach half the maximal activity. If the Km 
gets larger, then more substrate is required. Measuring the effect FABs have on Km, will show whether the 
FABs activate (lower Km) or inhibit (higher Km) the mutated enzyme. Km and Vmax were calculated as 
follows: 
-1/Km= -.013  
-1/Km= -.0025  
Method  
Effect of FABs on mutant IDH1 was measured using enzyme assay carried out in a micro 
plate reader. While holding [NADP] constant, concentrations of ICA (substrate) were 
increased. NADP is converted to NADPH, resulting in an increase in absorbance at 340 nm.  
